Temporal Importance in the Reinvention of Radiation Therapy
Jacob Scott, MD, DPhil, is not your average doctor. In his every day practice, Jacob leverages a multi-dimensional background. Studying astrophysics and nuclear engineering aboard a submarine, he utilizes his expertise in computer science and mathematical biology to improve patient care. With two innovative technologies, Jacob looks to maximize radiation therapy efficacy and minimize toxicity in his patients.
O’Neill Testifies in Front of Senate Judiciary Committee
In early June in Washington, D.C., Cleveland Clinic Innovations (CCI) Executive Director Pete O’Neill testified in front of a Senate Judiciary Committee on the state of patent eligibility in America. One of 45 witnesses across three days of testimony, O’Neill spoke to Cleveland Clinic’s perspective on the importance of having confidence that an issued patent that follows guidance of the USPTO will not be invalidated based on court case-law. His testimony addressed Cleveland Clinic’s experience with patenting the diagnostic MPO test, which led to the creation of Cleveland HeartLab. Specifically, he spoke about cases before federal district courts whereby the court rulings resulted in losing the protection of the MPO patents.
AI and the Evolving Nature of Drug Discovery
In turning molecules into medicines, most studies report success 1 out of 10 tries. Yet rapid discovery and development of safe, effective drugs is crucial to moving the needle in healthcare. With unlimited chemical combinations, discovering new candidate medicines is a lengthy, intricate process. Post discovery, drug development is also slow. Undoubtedly, medications require careful progression from bench to bedside to prevent oversight and harm in the ultimate consumers. But with the goal of breakthrough treatments for all conditions, trending HIT applications just might get equally safe medication to the hands of patients sooner.